drugset / Trial / NCT01121380
A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to test the safety, tolerability and pharmacokinetics of BL-1021 in healthy volunteers. Subsequent clinical studies will be designed to test the safety and efficacy of BL-1021 in patients with neuropathic pain based on data obtained from the proposal trial described below.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-10
- Completion
- 2011-10
Outcome
Outcome not reported
Stopped (Business): “Sponsor strategy change”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BL-1021 | Small molecule | 10 mg | Oral |
| Subject | BL-1021 | Small molecule | 20 mg | Oral |
| Subject | BL-1021 | Small molecule | 40 mg | Oral |
| Subject | BL-1021 | Small molecule | 80 mg | Oral |
Indications
No indication recorded.